Literature DB >> 17209129

RNAi pathway is functional in peripheral nerve axons.

Alexander K Murashov1, Vishnu Chintalgattu, Rustem R Islamov, Teresa E Lever, Elena S Pak, Paulina L Sierpinski, Laxmansa C Katwa, Michael R Van Scott.   

Abstract

Recent observations demonstrated that translation of mRNAs may occur in axonal processes at sites that are long distances away from the neuronal perikaria. While axonal protein synthesis has been documented in several studies, the mechanism of its regulation remains unclear. The aim of this study was to investigate whether RNA interference (RNAi) may be one of the pathways that control local protein synthesis in axons. Here we show that sciatic nerve contains Argonaute2 nuclease, fragile X mental retardation protein, p100 nuclease, and Gemin3 helicase-components of the RNA-induced silencing complex (RISC). Application of short-interfering RNAs against neuronal beta-tubulin to the sciatic nerve initiated RISC formation, causing a decrease in levels of neuronal beta-tubulin III mRNA and corresponding protein, as well as a significant reduction in retrograde labeling of lumbar motor neurons. Our observations indicate that RNAi is functional in peripheral mammalian axons and is independent from the neuronal cell body or Schwann cells. We introduce a concept of local regulation of axonal translation via RNAi.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17209129     DOI: 10.1096/fj.06-6155com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  57 in total

1.  Long-term exposure to black carbon, cognition and single nucleotide polymorphisms in microRNA processing genes in older men.

Authors:  Elena Colicino; Giulia Giuliano; Melinda C Power; Johanna Lepeule; Elissa H Wilker; Pantel Vokonas; Kasey J M Brennan; Serena Fossati; Mirjam Hoxha; Avron Spiro; Marc G Weisskopf; Joel Schwartz; Andrea A Baccarelli
Journal:  Environ Int       Date:  2015-12-24       Impact factor: 9.621

2.  Fragile X mental retardation protein (FMRP) and the spinal sensory system.

Authors:  Theodore J Price; Ohannes K Melemedjian
Journal:  Results Probl Cell Differ       Date:  2012

3.  Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication.

Authors:  Li Xing; Elliott Kieff
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 4.  Local protein synthesis in axonal growth cones: what is next?

Authors:  Saulius Satkauskas; Dominique Bagnard
Journal:  Cell Adh Migr       Date:  2007-10-11       Impact factor: 3.405

Review 5.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

6.  MicroRNA machinery responds to peripheral nerve lesion in an injury-regulated pattern.

Authors:  D Wu; M Raafat; E Pak; S Hammond; A K Murashov
Journal:  Neuroscience       Date:  2011-06-12       Impact factor: 3.590

7.  Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a.

Authors:  Jonathan D Verrier; Pierre Lau; Lynn Hudson; Alexander K Murashov; Rolf Renne; Lucia Notterpek
Journal:  Glia       Date:  2009-09       Impact factor: 7.452

8.  Identification of precursor microRNAs within distal axons of sensory neuron.

Authors:  Hak Hee Kim; Paul Kim; Monichan Phay; Soonmoon Yoo
Journal:  J Neurochem       Date:  2015-05-23       Impact factor: 5.372

9.  Neurogenesis and neurite outgrowth in the spinal cord of chicken embryos and in primary cultures of spinal neurons following knockdown of Class III beta tubulin with antisense morpholinos.

Authors:  Richard P Tucker; Ha Tran; Qizhi Gong
Journal:  Protoplasma       Date:  2008-09-30       Impact factor: 3.356

10.  Fragile X Mental Retardation Protein is Involved in Protein Synthesis-Dependent Collapse of Growth Cones Induced by Semaphorin-3A.

Authors:  Chanxia Li; Gary J Bassell; Yukio Sasaki
Journal:  Front Neural Circuits       Date:  2009-09-15       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.